Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rashmi Ravichandran

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Nature|December 18, 2024
Hierarchical design of pseudosymmetric protein nanocagesQuinton M Dowling, Young-Jun Park, Chelsea N Fries, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2021
Ultrapotent miniproteins targeting the receptor-binding domain protect against SARS-CoV-2 infection and disease in miceJames Brett Case, Rita E Chen, Longxing Cao, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Mannosylated nanoparticle immunogens enhance the circumsporozoite protein-specific B cell response and improve protection against sporozoite challengeCourtney E McDougal, Mark D Langowski, Daria Nikolaeva, et al.
Cell Host & Microbe|June 30, 2021
Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and diseaseJames Brett Case, Rita E Chen, Longxing Cao, et al.
Journal of the American Chemical Society|June 9, 2025
The Binding Affinities of Serum Proteins to NanoparticlesBenjamin P Stordy, Zahra Sepahi, Gabriel D Patrón, et al.
Nature Biotechnology|November 1, 2022
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapyAlfredo Quijano-Rubio, Aladdin M Bhuiyan, Huilin Yang, et al.
Process Biochemistry (Barking, London, England)|April 4, 2023
Process development of a SARS-CoV-2 nanoparticle vaccineDiandra Martinez-Cano, Rashmi Ravichandran, Huong Le, et al.
Nature Communications|January 24, 2026
A stabilized tandem antigen chimera that elicits potent malaria transmission-reducing activityDanton Ivanochko, Kazutoyo Miura, Sophia Hailemariam, et al.
NPJ Vaccines|May 5, 2025
Elicitation of liver-stage immunity by nanoparticle immunogens displaying P. falciparum CSP-derived antigensMark D Langowski, Joseph R Francica, Alex L Roederer, et al.
Nature Communications|November 26, 2022
Induction of cross-neutralizing antibodies by a permuted hepatitis C virus glycoprotein nanoparticle vaccine candidateKwinten Sliepen, Laura Radić, Joan Capella-Pujol, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Nature|December 18, 2024
Hierarchical design of pseudosymmetric protein nanocagesQuinton M Dowling, Young-Jun Park, Chelsea N Fries, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2021
Ultrapotent miniproteins targeting the receptor-binding domain protect against SARS-CoV-2 infection and disease in miceJames Brett Case, Rita E Chen, Longxing Cao, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Mannosylated nanoparticle immunogens enhance the circumsporozoite protein-specific B cell response and improve protection against sporozoite challengeCourtney E McDougal, Mark D Langowski, Daria Nikolaeva, et al.
Cell Host & Microbe|June 30, 2021
Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and diseaseJames Brett Case, Rita E Chen, Longxing Cao, et al.
Journal of the American Chemical Society|June 9, 2025
The Binding Affinities of Serum Proteins to NanoparticlesBenjamin P Stordy, Zahra Sepahi, Gabriel D Patrón, et al.
Nature Biotechnology|November 1, 2022
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapyAlfredo Quijano-Rubio, Aladdin M Bhuiyan, Huilin Yang, et al.
Process Biochemistry (Barking, London, England)|April 4, 2023
Process development of a SARS-CoV-2 nanoparticle vaccineDiandra Martinez-Cano, Rashmi Ravichandran, Huong Le, et al.
Nature Communications|January 24, 2026
A stabilized tandem antigen chimera that elicits potent malaria transmission-reducing activityDanton Ivanochko, Kazutoyo Miura, Sophia Hailemariam, et al.
NPJ Vaccines|May 5, 2025
Elicitation of liver-stage immunity by nanoparticle immunogens displaying P. falciparum CSP-derived antigensMark D Langowski, Joseph R Francica, Alex L Roederer, et al.
Nature Communications|November 26, 2022
Induction of cross-neutralizing antibodies by a permuted hepatitis C virus glycoprotein nanoparticle vaccine candidateKwinten Sliepen, Laura Radić, Joan Capella-Pujol, et al.
Pageof 5